![Scott Coiante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 229 676 $ in data 31/05/2026
Scott M.
Coiante is currently Chief Financial Officer & Senior Vice President at Lexicon Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Coiante was Chief Financial Officer, Treasurer & Senior Vice President at Agile Therapeutics, Inc. from 2023 to 2024.
From 2019 to 2023, served as Chief Financial Officer & Senior Vice President at Aprea Therapeutics AB and as CFO, Secretary, Treasurer & Senior Vice President at Aprea Therapeutics, Inc. From 2010 to 2019, held the roles of CFO, Principal Accounting Officer & Senior Vice President at Agile Therapeutics, Inc. Between 2005 and 2010, was Treasurer, Chief Accounting Officer & VP-Finance at Medarex, Inc. Worked as Head-Financial Reporting at Ernst & Young LLP from 1989 to 2000.
Was a Member of the New Jersey Technology Council.
Education includes undergraduate studies at Villanova University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/03/2026 | 105.356 ( 0,02% ) | 229 676 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 02/01/2025 |
| Società | Posizione | Fine |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 26/08/2024 |
| APREA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 30/01/2023 |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Direttore Finanziario/CFO | 01/01/2023 |
| AGILE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 05/08/2019 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Direttore Finanziario/CFO | 01/01/2005 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Agile Therapeutics, Inc.
 Agile Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormonal contraceptive products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Technology Council
 New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services Provides business development, education and advocacy services | Commercial Services |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
